Skip to content

MAPMG Regional Programs include the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP), the Commission on Cancer (CoC), and the Cancer Survivorship Program. These programs work to better the quality of care, improve standards, and monitor care effectively to uphold the mission of MAPMG as an innovator in patient care.

 ACS National Surgical Quality Improvement Program (NSQIP)

 

NSQIP Program Structure and Outcomes

  • ACS NSQIP is a variable-based data registry designed to improve hospital-wide quality across all surgical departments, helping surgical and quality teams make informed decisions about the improvement of quality of care while reducing complications and costs
  • Participating hospitals earn the distinction as an ACS Surgical Quality Partner (SQP)
  • Within NSQIP, 62 percent of hospitals reduce morbidity, 71 percent reduce mortality, and between 200 and 500 complications are prevented annually

Resources (Tab):

Learn More about ACS NSQIP Modules

Learn More about ACS NSQIP

Meet the MAPMG NSQIP Team

Dr. Rahul Tevar, MD                                                                                                             

Dr. Tevar is the regional medical director for Perioperative Services for the Mid-Atlantic Permanente Medical Group. Dr. Tevar graduated from Northwestern University and received his medical degree from the University of Illinois in Chicago. He then completed his residency and fellowship training in general surgical and surgical critical care at The George Washington University.  Since joining MAPMG in 2009, he has had many leadership roles within the organization, including chief of surgery, medical director of our ambulatory surgery centers in the District of Columbia and suburban Maryland, and program director of Robotic Surgery. He led the effort that resulted in Kaiser Permanente of the Mid-Atlantic States becoming the first ambulatory surgery pilot program to enter the American College of Surgeons National Surgical Quality Improvement Program and serves as that program’s surgeon Champion

 

 

 

 

Dr. Michael Horberg, MD, MAS, FACP, FIDSA  

Dr. Horberg is the Associate Medical Director for Kaiser Permanente Mid-Atlantic Permanente Medical Group (KPMAS MAPMG). He is responsible for Research, Medical Education, Community Health, Medicaid, Genomics, HIV and STI, Complex Care, LGBTQI+ Health, and Infection Prevention. Dr. Horberg attended Boston University Medical School and received his Master of Advanced Studies from the University of California San Francisco. He completed his residency in internal medicine at the University of Chicago Michael Reese Hospital and Medical Center. At MAPMG, he acts as the Executive Director for research, Director for Medical Education, and Executive Sponsor for the Commission on Cancer Accreditation and National Surgical Quality Improvement Program

 

 

Commission on Cancer (CoC) 

 

Commission on Cancer Structure and Outcomes

  • The CoC is dedicated to improving survival and quality of life for patients with cancer by setting and raising standards through cancer prevention, research, education, and monitoring of comprehensive quality care
  • CoC accreditation includes data and feedback from the CoC’s National Cancer Database (NCDB) to assess hospital performance using nationally recognized quality of cancer care measures
  • Accredited cancer programs undergo an on-site visit on a triennial basis. A trained CoC site reviewer visits the cancer program and reviews required cancer program activity documentation to ensure standards are met.
  • 2020 Standards: Optimal Resources for Cancer Care is continuously revised to include the most current requirements for CoC Accreditation
  • Kaiser Permanente of the Mid-Atlantic States has been accredited as a Comprehensive Community Cancer Program since 2018

Resources (tab)

2020 Standards and Resources

Learn More about the CoC

Meet the MAPMG CoC Team

Dr. Edward Tsong, MD 

Dr. Tsong, an otolaryngology-head and neck surgery specialist, has been a Kaiser Permanente physician since completing his surgical training in 2005, with a special clinical interest in treating head and neck cancers. He received his medical education from the New York University School of Medicine and completed his residency at the University of Maryland Medical Center in Baltimore, Maryland.

 

 

 

 

Dr. Michael Horberg, MD, MAS, FACP, FIDSA           

Cancer Survivorship Program

Cancer Survivorship Structure and Outcomes

  • The Cancer Survivorship program establishes a survivorship tracking tool for surveillance per the National Comprehensive Cancer Network (NCCN) guidelines
  • Establishes contact with patients through an outreach process for patients with colon cancer and non-small cell lung cancer
                  • For patients with colon cancer stages I through III, tracking begins at the completion of treatment and continues through 5 years
                  • For patients with non-small cell lung cancer stages I through III, tracking begins at the completion of treatment and continues indefinitely
  • Works to ensure that patients who have completed cancer treatment maintain the recommended NCCN follow-up schedule for surveillance

Resources (tab):

Learn More about Cancer Survivorship at MAPMG

Meet the Cancer Survivorship Team

Emily Burg, PA-C

Emily Burg has been working as a physician assistant since 2012 after graduating from the Duke University Physician Assistant Program with a master’s in health sciences. Prior to that, she received her bachelor’s in health sciences at James Madison University. After completing her physician assistant studies, Emily spent 10 years caring for patients at George Washington University Hospital, between inpatient hospital medicine and occupational health, and on the psychiatric unit. As part of the team to initiate the tumor survivorship program with MAPMG as the new tumor research survivorship coordinator, she looks forward to continuing to play a significant role in making lifelong positive impacts for patients, while they navigate this part of cancer treatment.

 

 

 

Back To Top